The has just written a letter to pharma-giant AbbVie, asking the company to cease running an advertisement for a migraine drug that features tennis legend . The letter details that the advertisement for Ubrelvy 'makes false or misleading representations' about the drug, and might lead migraine patients to believe that, 'all patients who take Ubrelvy can expect their migraine pain to be eliminated after a single dose of Ubrelvy, when this has not been demonstrated'.It asks the company to come up with a plan to cease running the advertisement or discontinue distribution of the drug.
Load More
Load More
